Total amount raised
$65.3 Millions
Latest funding date
09/01/2024
Location
GC Therapeutics is pioneering the field of cell therapy with its innovative TFome™ platform, designed to streamline the development and scaling of induced pluripotent stem cell (iPSC) therapies. The platform leverages synthetic biology, gene editing, cell engineering, and machine learning to deliver iPSC-based medicines more rapidly and efficiently.
Keep reading to explore the intricacies of GC Therapeutics' fundraising journey and the investors backing this groundbreaking platform.
What Is GC Therapeutics?
GC Therapeutics is a biotechnology company specializing in cell therapy and regenerative medicine. The company leverages its TFome™ platform to enhance the scalability and accessibility of induced pluripotent stem cell (iPSC) therapies.
Founded by George Church, Ph.D., and Parastoo Khoshakhlagh, Ph.D., GC Therapeutics is dedicated to advancing cell therapy programs targeting gastrointestinal, neurological, and immunological diseases. The team is composed of visionary scientists and operators committed to improving patient outcomes through innovative technology.
How Much Funding Has GC Therapeutics Raised?
- Seed Round
- Amount Raised: $339.9K
- Date: October 2023
- Series A
- Amount Raised: $65M
- Date: September 2024
- Lead Investors: Alumni Ventures, Cormorant Asset Management
GC Therapeutics has raised a total of $65.34M.
Key Investors
- Alumni Ventures
- Details: Alumni Ventures is a venture capital firm that provides individual investors with access to venture capital opportunities. They focus on investing in high-growth startups across various industries.
- Investment Focus Areas: Technology, healthcare, consumer products
- Notable Investments: SpaceX, Robinhood, DraftKings
- Cormorant Asset Management
- Details: Cormorant Asset Management is a healthcare-focused investment firm that manages a range of investment strategies. They are known for their deep expertise in the biotechnology and pharmaceutical sectors.
- Investment Focus Areas: Biotechnology, pharmaceuticals, medical devices
- Notable Investments: Moderna, CRISPR Therapeutics, Allogene Therapeutics
Use Clay to Get Funding Data
Sales professionals, take advantage of Clay’s platform to access comprehensive fundraising data on companies like GC Therapeutics and gather other critical business insights.
Sign up for free to start leveraging these powerful tools today.
